Abstract: An optical lens assembly. The optical lens assembly comprises a lens barrel, and first to sixth lenses. The refractive power of the fifth lens and the refractive power of the sixth lens are positive-negative opposite, and an image-side surface of the fifth lens is a convex surface. The lens barrel further comprises a fourth spacer and a fifth spacer, the fourth spacer being disposed between the fourth lens and the fifth lens, and the fifth spacer being disposed between the fifth lens and the sixth lens. An axial distance EP45 from an image-side surface of the fourth spacer to an object-side surface of the fifth spacer, a center thickness CT5 of the fifth lens, an effective focal length f5 of the fifth lens, an effective focal length f6 of the sixth lens and a radius of curvature R10 of the image-side surface of the fifth lens satisfy: ?0.5<EP45/CT5*|f5+f6|/R10<0.

Abstract: A magnetic field enhancing component and a magnetic field enhancing device. The magnetic field enhancing component includes a first dielectric layer, a first electrode layer, a second electrode layer, a third electrode layer, a fourth electrode layer, and a control circuit. The first electrode layer and the second electrode layer are arranged on a first surface of the first dielectric layer. The third electrode layer and the fourth electrode layer are arranged on a second surface of the first dielectric layer. The first electrode layer and the third electrode layer form a second structural capacitor. The second electrode layer and the fourth electrode layer form a third structural capacitor. The control circuit is connected between the first electrode layer and the second electrode layer, and includes a third capacitor, a first inductor, and a first switch circuit. The first inductor and the first switch circuit are connected in series, then is connected to the third capacitor in parallel.

Abstract: Provided herein are compounds of the Formula I: and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, wherein R1, R2, R9, X1 and G are as defined herein, which are inhibitors of one or more TAM kinases and/or c-Met kinase, and are useful in the treatment and prevention of diseases which can be treated with a TAM kinase inhibitor and/or a c-Met kinase inhibitor.

Abstract: A method for improving a process model for a patterning process, the method including obtaining a) a measured contour from an image capture device, and b) a simulated contour generated from a simulation of the process model. The method also includes aligning the measured contour with the simulated contour by determining an offset between the measured contour and the simulated contour. The process model is calibrated to reduce a difference, computed based on the determined offset, between the simulated contour and the measured contour.

Abstract: Compounds that inhibit KRas G12D. In particular, compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor, and in particular, methods of treating cancer. The compounds have a general structure represented by Formula (I): or a pharmaceutically acceptable salt thereof.

Abstract: A method of making an elevator load bearing member includes unidirectional weaving a plurality of load bearing fibers including at least a first material and a second material. A melting point of the first material is higher than a melting point of the second material. The method includes bonding the load bearing fibers together by at least partially melting at least some of the second material and coating the plurality of load bearing fibers.

Abstract: Provided are a brucine gel plaster and a preparation method therefor. The brucine gel plaster comprises, calculated by weight percentage, 0.3%-2% of brucine, 3%-10% of a framework material, 20%-50% of a humectant and a co-solvent, 0.1%-2% of a crosslinking agent and a crosslinking regulator, and the balance of water, as well as a backing layer and an anti-adhesive layer. The brucine gel plaster uses simple medicinal excipients, does not use a transdermal enhancer, has good skin compatibility, is moisturizing and breathable, is non-irritating to the skin and mucous membranes, has a large drug load, and can be applied to repeatedly. The plaster is used for treating or ameliorating related diseases requiring anti-inflammation and analgesia such as osteoarthritis, rheumatic arthritis and rheumatoid arthritis.

Abstract: The invention provides compounds of Formula (I): as further described herein, as well as pharmaceutical compositions comprising such compounds, and methods to use the compounds and pharmaceutical compositions for treatment of certain viral disorders, including influenza.

Abstract: Disclosed is a multi-scale fusion defogging method based on a stacked hourglass network, including inputting a foggy image into a preset image defogging network; and outputting a fogless image after the foggy image is processed by the image defogging network. The image defogging network includes a 7×7 convolutional layer, a stacked hourglass module, a feature fusion, a multi-scale jump connection module, a 1×1 convolutional layer, a 3×3 convolutional layer, a hierarchical attention distillation module, the 3×3 convolutional layer and the 1×1 convolutional layer connected sequentially.

Abstract: This application discloses an electrode assembly, a battery cell, a battery, and an electric device. The electrode assembly may include a first electrode plate and a second electrode plate that have opposite polarities, where the first electrode plate and the second electrode plate may be stacked. The first electrode plate may include a first active substance portion and a plurality of first inactive substance portions protruding from the first active substance portion, and the plurality of first inactive substance portions may be stacked. A connection layer may be disposed between at least two adjacent first inactive substance portions, and the connection layer may be spaced from the first active substance portion in a first direction and connect two adjacent first inactive substance portions, where the first direction is a direction in which the first inactive substance portions protrude from the first active substance portion.

Abstract: A film plating machine and electroplating production line are provided. The film plating machine has a plating solution tank, conductive substrate film conveying devices and a power supply. A plating solution and an anode member are provided in the plating solution tank. The conductive substrate film conveying devices are provided at both sides of the plating solution tank and configured to clamp two opposite side edges of a horizontally-placed conductive substrate film and drive the conductive substrate film to horizontally enter and exit the plating solution tank in a first direction. A positive electrode of the power supply is electrically connected with the anode member, and a negative electrode of the power supply is electrically connected with the conductive substrate film through the conductive substrate film conveying devices.

Abstract: A method for constructing a design concept generation network (DCGN) and a method for automatically generating a conceptual scheme are provided. A DCGN includes a Transformer encoder, a Transformer decoder, an importance constraint matrix generation module, an importance constraint embedding layer, a cross-attention (CA) layer, and an optimization module. A word importance constraint is ingeniously introduced based on an attention mechanism of a Transformer to record input word constraint information contained in a generated text sequence. This can effectively ensure the reliability and effectiveness of a generated conceptual scheme and is conducive to capturing potential semantic importance information and implementing semantic knowledge reasoning.

Abstract: Use of pentoxifylline (PTX) in preparation of a medicament for repairing endothelial glycocalyx damage, and belongs to the technical field of medicine. A chlorine-induced endothelial glycocalyx damage model is established. After the endothelial glycocalyx damage model is successfully established, the PTX is intraperitoneally injected into a rat with endothelial glycocalyx damage. The result shows that the PTX effectively repairs shedding of glycosaminoglycans and syndecans in the endothelial glycocalyx damage and significantly downregulates the expression of inflammatory factors including tumor necrosis factor alpha (TNF-?), interleukin-6 (IL-6), and matrix metallopeptidase 13 (MMP-13). Therefore, the PTX can effectively repair the endothelial glycocalyx damage, providing a new theoretical basis for repairing the endothelial glycocalyx damage. Furthermore, with high safety, the PTX has the prospect of being developed into the medicament for repairing the endothelial glycocalyx damage.

Abstract: A load-bearing assembly according to an example of the present disclosure includes at least one tension member. The tension member has a resin, reinforcement fibers, and at least one additive that provides a fire-resistance to the tension member. A jacket material covers the at least one tension member. An alternate load-bearing assembly and a method of making a load-bearing assembly are also disclosed.

Abstract: A semiconductor device includes a drift region, a first electrode structure, and a second electrode structure, and the first electrode structure and the second electrode structure are located on a same side of the drift region. The first electrode structure includes a first insulation layer and a first electrode. The first insulation layer is located on a periphery of the first electrode. The second electrode structure includes a second insulation layer and a second electrode. The second insulation layer is located on a periphery of the second electrode. A buffer structure is disposed between the first electrode and the second electrode, and the buffer structure is configured to increase accumulation of carriers in the drift region when the semiconductor device is turned on. The buffer structure is disposed between the first electrode and the second electrode, so that flow of carriers stored in the drift region is buffered.

Abstract: The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.

Abstract: A data receiving method includes: receiving a destination address in a preamble segment; receiving a first duration and a second duration after the destination address in the preamble segment when the destination address is different from a local address, the first duration being a remaining duration before a beginning of transmission of valid data, and the second duration being a duration required for transmitting the valid data; determining a dormant duration according to the first duration and the second duration, and controlling a local device to enter a low power mode; and waking up the local device after a duration in the low power mode reaches the dormant duration.

Abstract: An electronic sports data processing method includes, in response to an electronic sports terminal in a target local electronic sports region being determined by a 5G private network to satisfy a terminal access condition, receiving electronic sports service data carrying access identification information transmitted by the electronic sports terminal, searching, in service routing information associated with a target base station in the target local electronic sports region, for target service routing information that is same as the access identification information, and transmitting the electronic sports service data to a target local electronic sports server corresponding to the access identification information upon finding the target service routing information, so that the target local electronic sports server obtains electronic sports response data of an electronic sports service based on the electronic sports service data.

Abstract: Embodiments of this disclosure provide a motion state detection apparatus and method based on wireless signals and a system, in which variations of energy distribution of reflection points with time are calculated according to wireless signals reflected from a space where an object that is detected is located, and a motion state of the object is determined according to the variations. Thus, the training of the recognition model is not needed, the detection process is simple and detection results are reliable, and are applicable to various different application scenarios.

Abstract: A method including acquiring a physical address of one or more devices to be accessed, generating an access key corresponding to each physical address the one or more devices, generating, based on the access keys, an association relationship between one or more physical addresses and a corresponding access key, and transmitting the association relationship to an access point device and transmitting the access key included in the association relationship to a corresponding device to be accessed, wherein the access point device verifies, based on the association relationship, an access request initiated by the corresponding device to be accessed based on the access key.